NCT00894374已完成1 期
A Single-Dose Bioequivalence Study Comparing Artesunate Tablet (Pfizer) To Arsuamoon® Tablets (Guilin-China) In Healthy Subjects
适应症
干预措施
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- Pfizer
- 入组人数
- 40
- 试验地点
- 1
- 主要终点
- AUC and Cmax of active metabolite of artesunate
研究概览
简要总结
The study will determine if artesunate tablet (Pfizer), an antimalarial agent, is pharmaceutically equivalent to Arsuamoon® tablets (Guilin-China).
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Crossover
- 主要目的
- Basic Science
- 盲法
- None
入排标准
- 年龄范围
- 21 Years 至 55 Years（Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Healthy male and/or female subjects between the ages of 21 and 55 years, inclusive.
- •BMI of 18 to 30 kg/m2; and a total body weight >45 kg (99 lbs).
- •An informed consent document signed and dated by the subject or a legally acceptable representative.
排除标准
- •Evidence or history of clinically significant abnormalities.
- •A positive urine drug screen, history of regular alcohol consumption.
研究组 & 干预措施
Artesunate (Pfizer)
Experimental
干预措施: Artesunate (Test) (Drug)
Artesunate (Arsuamoon® Tablets Guilin-China)
Active Comparator
干预措施: Artesunate (Comparator) (Drug)
结局指标
主要结局
AUC and Cmax of active metabolite of artesunate
时间窗: 30-Aug-2009
次要结局
- Tolerability(30-Aug-2009)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
4 期
A Study Comparing Blood Levels After Single-Dose Administration Of Artesunate Sachets (Pfizer) Versus Single-Dose Administration Of Arsuamoon® Tablets (Guilin-China) In Healthy SubjectsHealthy VolunteersNCT00875030Pfizer40
已完成
1 期
A Bioequivalence Study Comparing Amodiaquine Tablet (Pfizer) To Amodiaquine Tablets (Arsuamoon-Guilin China) In Healthy SubjectsFalciparum MalariaNCT00894660Pfizer38
终止
不适用
Artesunate Plus Sulfadoxine-pyrimethamine Pharmacokinetics, Efficacy, Gametocytes Carriage and Birth Outcomes in Pregnant Women With MalariaMalariaNCT00331708Professor Karen I Barnes3
已完成
不适用
A Randomised Trial of Artekin and Artesunate & Amodiaquine for Uncomplicated Malaria in Timika, Papua, Indonesia.Malaria, FalciparumMalaria, VivaxNCT00157885Menzies School of Health Research400
尚未招募
1 期
Bioequivalence Study of Sulfadoxine/Pyrimethamine 500/25 mg Dispersible TabletFastingNCT06522763Swiss Pharma Nigeria Limited46